Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > 5-[4′-(Bromomethyl)[1,1′-biphenyl]-2-yl]-1-(triphenylmethyl)-1H-tetrazole

5-[4′-(Bromomethyl)[1,1′-biphenyl]-2-yl]-1-(triphenylmethyl)-1H-tetrazole

5-[4′-(Bromomethyl)[1,1′-biphenyl]-2-yl]-1-(triphenylmethyl)-1H-tetrazole structure

5-[4′-(Bromomethyl)[1,1′-biphenyl]-2-yl]-1-(triphenylmethyl)-1H-tetrazole 

structure
  • CAS No:

    124750-51-2

  • Formula:

    C33H25BrN4

  • Chemical Name:

    5-[4′-(Bromomethyl)[1,1′-biphenyl]-2-yl]-1-(triphenylmethyl)-1H-tetrazole

  • Synonyms:

    1H-Tetrazole,5-[4′-(bromomethyl)[1,1′-biphenyl]-2-yl]-1-(triphenylmethyl)-;5-[4′-(Bromomethyl)[1,1′-biphenyl]-2-yl]-1-(triphenylmethyl)-1H-tetrazole;4′-Bromomethyl-2-(1-trityl-1H-tetrazol-5-yl)biphenyl;N-Triphenylmethyl-5-[2-(4′-bromomethylbiphenyl)]tetrazole;4-Bromomethyl-2′-[N-triphenylmethyl-1H-tetrazol-5-yl]biphenyl;4′-Bromomethyl-2-(1-triphenylmethyltetrazol-5-yl)biphenyl;[2′-(N-Trityltetrazol-5-yl)biphenyl-4-yl]methyl bromide;[2′-(1-Trityl-1H-tetrazol-5-yl)biphenyl-4-yl]methyl bromide;[2′-(Triphenylmethyl-1H-tetrazol-5-yl)biphenyl-4-yl]methyl bromide;4′-Bromomethyl-2-(N-trityl-1H-tetrazol-5-yl)biphenyl;N-Triphenylmethyl-5-[4′-(bromomethyl)biphenyl-2-yl]tetrazole;5-[4′-(Bromomethyl)biphenyl-2-yl]-N-(triphenylmethyl)tetrazole;4-[2′-(N-Triphenylmethyltetrazol-5-yl)phenyl]benzyl bromide;5-(4′-Bromomethylbiphenyl-2-yl)-1-trityl-1H-tetrazole;1-Triphenylmethyl-5-[4′-(bromomethyl)biphenyl-2-yl]tetrazole

  • Categories:

    Pharmaceutical Intermediates  >  Cardiovascular Agents

Description

Off-White Solid

5-[4′-(Bromomethyl)[1,1′-biphenyl]-2-yl]-1-(triphenylmethyl)-1H-tetrazole Basic Attributes

557.48

557.48

1592732-453-0

DTXSID80434768

Characteristics

43.6

8.2

off-white solid

1.28±0.1 g/cm3(Predicted)

135-137 °C

61°C/12mmHg(lit.)

388.3±35.7 °C

1.660

-20°C Freezer

0mmHg at 25°C

Safety Information

III

6.1

UN 2811 6.1/PG III

Moisture Sensitive

|Danger|H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]|P261, P264, P270, P271, P280, P301+P310, P302+P352, P304+P340, P305+P351+P338, P312, P321, P330, P332+P313, P337+P313, P362, P403+P233, P405, and P501|Aggregated GHS information provided by 45 companies from 6 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

5-[4′-(Bromomethyl)[1,1′-biphenyl]-2-yl]-1-(triphenylmethyl)-1H-tetrazole Use and Manufacturing

An intermediate in the synthesis of Losartan and Valsartan Used as a drug intermediate of Irbesartan

Computed Properties

Molecular Weight:557.5
XLogP3:8.2
Hydrogen Bond Acceptor Count:3
Rotatable Bond Count:7
Exact Mass:556.12626
Monoisotopic Mass:556.12626
Topological Polar Surface Area:43.6
Heavy Atom Count:38
Complexity:660
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Recommended Suppliers of 5-[4′-(Bromomethyl)[1,1′-biphenyl]-2-yl]-1-(triphenylmethyl)-1H-tetrazole

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.